Unstable federal research funding and reductions in health care revenue for academic medical centers threatens to undermine the nation’s biomedical research enterprise, and in turn clinical medicine, which the nation needs now more than ever.
National Institutes of Health Director Francis Collins, M.D., Ph.D., will deliver a special Discovery Lecture at Vanderbilt University Medical Center next Thursday, May 28.
The enzyme alkaline phosphatase may provide a new therapeutic option for women at high risk of pregnancy complications due to bacterial toxin exposure.
Vanderbilt University researchers have received a five-year, $9 million grant from the National Institutes of Health (NIH) to design more effective flu vaccines and novel antibody therapies.
A metabolic change in adult stem cells makes them less “fit” for regenerative heart therapies, suggesting that strategies to prevent this response may boost the therapeutic usefulness of the cells.
On May 28-29 at Vanderbilt, the Precision Medicine Initiative Working Group of the Advisory Committee to the Director of the National Institutes of Health (NIH) will hold a public workshop devoted to research cohorts and electronic health records.
Accessibility Tools